Literature DB >> 22213019

Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Saeed R Khan1.   

Abstract

Epidemiological studies have provided the evidence for association between nephrolithiasis and a number of cardiovascular diseases including hypertension, diabetes, chronic kidney disease, metabolic syndrome. Many of the co-morbidities may not only lead to stone disease but also be triggered by it. Nephrolithiasis is a risk factor for development of hypertension and have higher prevalence of diabetes mellitus and some hypertensive and diabetic patients are at greater risk for stone formation. An analysis of the association between stone disease and other simultaneously appearing disorders, as well as factors involved in their pathogenesis, may provide an insight into stone formation and improved therapies for stone recurrence and prevention. It is our hypothesis that association between stone formation and development of co-morbidities is a result of certain common pathological features. Review of the recent literature indicates that production of reactive oxygen species (ROS) and development of oxidative stress (OS) may be such a common pathway. OS is a common feature of all cardiovascular diseases (CVD) including hypertension, diabetes mellitus, atherosclerosis and myocardial infarct. There is increasing evidence that ROS are also produced during idiopathic calcium oxalate (CaOx) nephrolithiasis. Both tissue culture and animal model studies demonstrate that ROS are produced during interaction between CaOx/calcium phosphate (CaP) crystals and renal epithelial cells. Clinical studies have also provided evidence for the development of oxidative stress in the kidneys of stone forming patients. Renal disorders which lead to OS appear to be a continuum. Stress produced by one disorder may trigger the other under the right circumstances.

Entities:  

Mesh:

Year:  2012        PMID: 22213019      PMCID: PMC5683185          DOI: 10.1007/s00240-011-0448-9

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  201 in total

Review 1.  Molecular determinants of extracellular matrix mineralization in bone and blood vessels.

Authors:  Monzur Murshed; Marc D McKee
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

2.  Acute deterioration of renal function associated with enteric hyperoxaluria.

Authors:  R Wharton; V D'Agati; A M Magun; R Whitlock; C L Kunis; G B Appel
Journal:  Clin Nephrol       Date:  1990-09       Impact factor: 0.975

3.  Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.

Authors:  M T Moriyama; P A Glenton; S R Khan
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

4.  Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.

Authors:  Karsten Grote; Magdalene Ortmann; Gustavo Salguero; Carola Doerries; Ulf Landmesser; Maren Luchtefeld; Ralf P Brandes; Wilfried Gwinner; Thomas Tschernig; Ernst-Georg Brabant; Andreas Klos; Arnd Schaefer; Helmut Drexler; Bernhard Schieffer
Journal:  Cardiovasc Res       Date:  2006-05-26       Impact factor: 10.787

5.  Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis.

Authors:  Brian H Eisner; Sima P Porten; Seth K Bechis; Marshall L Stoller
Journal:  J Urol       Date:  2009-12-16       Impact factor: 7.450

6.  Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.

Authors:  Ho-Shiang Huang; Ming-Chieh Ma; Chau-Fong Chen; Jun Chen
Journal:  Urology       Date:  2003-12       Impact factor: 2.649

Review 7.  Contribution of polyol pathway to diabetes-induced oxidative stress.

Authors:  Stephen S M Chung; Eric C M Ho; Karen S L Lam; Sookja K Chung
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

8.  Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.

Authors:  Shamim Mushtaq; Anwar Ali Siddiqui; Zulfiqar Ali Naqvi; Ahmed Rattani; Jamsheer Talati; Carina Palmberg; Jawed Shafqat
Journal:  Clin Chim Acta       Date:  2007-05-26       Impact factor: 3.786

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

Review 10.  Physiopathology and etiology of stone formation in the kidney and the urinary tract.

Authors:  Andrew P Evan
Journal:  Pediatr Nephrol       Date:  2009-02-07       Impact factor: 3.714

View more
  54 in total

1.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 2.  The role of calcium phosphate in the development of Randall's plaques.

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2013-08-21       Impact factor: 3.436

3.  Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis.

Authors:  Wipawee Kittikowit; Uraiwan Waiwijit; Chanchai Boonla; Preecha Ruangvejvorachai; Chaowat Pimratana; Chagkrapan Predanon; Supoj Ratchanon; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2014-07-15       Impact factor: 3.436

4.  Oxidative stress and nephrolithiasis: a comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls.

Authors:  Chad R Tracy; Jonathan R Henning; Mark R Newton; Michael Aviram; M Bridget Zimmerman
Journal:  Urolithiasis       Date:  2014-08-02       Impact factor: 3.436

5.  Is oxidative stress related to childhood urolithiasis?

Authors:  Nilufer Göknar; Faruk Oktem; Engin Arı; Aysegul Doğan Demir; Emel Torun
Journal:  Pediatr Nephrol       Date:  2014-02-14       Impact factor: 3.714

6.  Independent and interactive effects of kidney stone formation and conventional risk factors for chronic kidney disease: a follow-up study of Japanese men.

Authors:  Ryosuke Ando; Teruo Nagaya; Sadao Suzuki; Hidekatsu Takahashi; Makoto Kawai; Kazumi Taguchi; Shuzo Hamamoto; Atsushi Okada; Takahiro Yasui
Journal:  Int Urol Nephrol       Date:  2021-02-24       Impact factor: 2.370

7.  Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats.

Authors:  Mohammad Reza Naghii; Eslam Eskandari; Mahmood Mofid; Mehdi Jafari; Mohammad Hossein Asadi
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

Review 8.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

Review 9.  Nephrolithiasis and hypertension: possible links and clinical implications.

Authors:  Adamasco Cupisti; Claudia D'Alessandro; Sara Samoni; Mario Meola; Maria Francesca Egidi
Journal:  J Nephrol       Date:  2014-02-28       Impact factor: 3.902

10.  Exposure of Madin-Darby canine kidney (MDCK) cells to oxalate and calcium oxalate crystals activates nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase.

Authors:  Aslam Khan; Karen Byer; Saeed R Khan
Journal:  Urology       Date:  2013-12-19       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.